130 related articles for article (PubMed ID: 10630784)
21. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs.
King JN; Mauron C; Kaiser G
Am J Vet Res; 1995 Dec; 56(12):1620-8. PubMed ID: 8599524
[TBL] [Abstract][Full Text] [Related]
22. Rat tissue concentrations of chlorimipramine, chlorpromazine and their N-demethylated metabolites after a single oral dose of the parent compounds.
Sgaragli GP; Valoti M; Palmi M; Frosini M; Giovannini MG; Bianchi L; Della Corte L
J Pharm Pharmacol; 1995 Sep; 47(9):782-90. PubMed ID: 8583393
[TBL] [Abstract][Full Text] [Related]
23. Application of HPLC with silica-phase and reversed-phase eluents for the determination of clomipramine and demethylated and 8-hydroxylated metabolites.
Coudoré F; Hourcade F; Molinier-Manoukian C; Eschalier A; Lavarenne J
J Anal Toxicol; 1996; 20(2):101-5. PubMed ID: 8868400
[TBL] [Abstract][Full Text] [Related]
24. Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients.
Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
Postgrad Med J; 1980; 56 Suppl 1():130-3. PubMed ID: 7393823
[TBL] [Abstract][Full Text] [Related]
25. Serum clomipramine and desmethylclomipramine levels in a CYP2C19 and CYP2D6 intermediate metabolizer.
Brown JT; Schneiderhan M; Eum S; Bishop JR
Pharmacogenomics; 2017 May; 18(7):601-605. PubMed ID: 28470111
[TBL] [Abstract][Full Text] [Related]
26. Clinical response and tricyclic plasma levels during treatment with clomipramine.
Della Corte L; Broadhurst AD; Sgaragli GP; Filippini S; Heeley AF; James HD; Faravelli C; Pazzagli A
Br J Psychiatry; 1979 Apr; 134():390-400. PubMed ID: 444789
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics of a sustained-release dosage form of clomipramine.
Herrera D; Mayet L; Galindo MC; Jung H
J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1488-93. PubMed ID: 11185671
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic studies in obsessional patients.
Luscombe DK; Marks IM
J Int Med Res; 1977; 5 Suppl 5():91-6. PubMed ID: 598610
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of clomipramine in depressive patients.
de Cuyper HJ; van Praag HM; Mulder-Hajonides WR; Westenberg HG; de Zeeuw RA
Psychiatry Res; 1981 Apr; 4(2):147-56. PubMed ID: 6939006
[TBL] [Abstract][Full Text] [Related]
30. Preliminary observations of the significance of monitoring tricyclic antidepressant plasma levels in the pediatric patient.
Dugas M; Zarifian E; Leheuzey MF; Rovei V; Durand G; Morselli PL
Ther Drug Monit; 1980; 2(4):307-14. PubMed ID: 7222184
[TBL] [Abstract][Full Text] [Related]
31. [Grapefruit juice as a contraindication? An approach in psychiatry].
Vandel P; Regina W; Reix I; Vandel S; Sechter D; Bizouard P
Encephale; 1999; 25(1):67-71. PubMed ID: 10205736
[TBL] [Abstract][Full Text] [Related]
32. Plasma level studies with clomipramine (anafranil).
Jones RB; Luscombe DK
J Int Med Res; 1977; 5(1 Suppl):98-107. PubMed ID: 863094
[TBL] [Abstract][Full Text] [Related]
33. Levetiracetam pharmacokinetics in healthy dogs following oral administration of single and multiple doses.
Moore SA; Muñana KR; Papich MG; Nettifee-Osborne J
Am J Vet Res; 2010 Mar; 71(3):337-41. PubMed ID: 20187836
[TBL] [Abstract][Full Text] [Related]
34. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.
Mavissakalian M; Jones B; Olson S; Perel JM
Psychopharmacol Bull; 1990; 26(1):119-22. PubMed ID: 2371366
[TBL] [Abstract][Full Text] [Related]
35. Unusual plasma level oscillations of clomipramine in man: a pharmacokinetic and pharmacodynamic dilemma.
De Zeeuw RA; Westenberg HG; Van Praag HM; De Cuyper H
Postgrad Med J; 1980; 56 Suppl 1():120-6. PubMed ID: 7393821
[TBL] [Abstract][Full Text] [Related]
36. High plasma concentrations of desmethylclomipramine after chronic administration of clomipramine to a poor metabolizer.
Balant-Gorgia AE; Balant L; Zysset T
Eur J Clin Pharmacol; 1987; 32(1):101-2. PubMed ID: 3582462
[TBL] [Abstract][Full Text] [Related]
37. Improved clean-up procedure for the high-performance liquid chromatographic assay of clomipramine and its demethylated metabolite in human plasma.
Altieri I; Pichini S; Pacifici R; Zuccaro P
J Chromatogr B Biomed Appl; 1995 Jul; 669(2):416-7. PubMed ID: 7581922
[TBL] [Abstract][Full Text] [Related]
38. Pronounced differences in the dispositon of clomipramine between Japanese and Swedish patients.
Shimoda K; Jerling M; Böttiger Y; Yasuda S; Morita S; Bertilsson L
J Clin Psychopharmacol; 1999 Oct; 19(5):393-400. PubMed ID: 10505580
[TBL] [Abstract][Full Text] [Related]
39. Effects of clomipramine hydrochloride on heart rate and rhythm in healthy dogs.
Pouchelon JL; Martel E; Champeroux P; Richard S; King JN
Am J Vet Res; 2000 Aug; 61(8):960-4. PubMed ID: 10951990
[TBL] [Abstract][Full Text] [Related]
40. [Clinical significance of plasma levels of clomipramine and its desmethylated and hydroxylated metabolites].
Noguchi T
Yakubutsu Seishin Kodo; 1993 Aug; 13(4):239-49. PubMed ID: 8237141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
